(Q49092700)

English

Pergolide therapy in Parkinson's disease.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

Pergolide therapy in Parkinson's disease. (English)

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

author name string

P Jeanty

1

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

M Van den Kerchove

2

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

A Lowenthal

3

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

H De Bruyne

4

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

publication date

1 January 1984

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

Journal of Neurology

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

231

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

3

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

148-152

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

https://scigraph.springernature.com/pub.10.1007/bf00313684

0 references

Pergolide in late-stage Parkinson disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoamines in the human neostriatum: Topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiologic disposition of pergolide

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologic Effects in Man of a Potent, Long-Acting Dopamine Receptor Agonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced Parkinson disease with pergolide

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of pergolide with central dopaminergic receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critical analysis of the disability in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanisms of action of L-dopa in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide, a potent long-acting dopamine-receptor agonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide mesylate and idiopathic Parkinson disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of pergolide, a potent dopamine agonist, in Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of motor side effects of chronic levodopa therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of patients who fail to respond to levodopa therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/6481422

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00313684

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 February 2018

http://europepmc.org/abstract/MED/6481422

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49092700&oldid=1386679380"